Stocks / ETF

XBIETF

State Street SPDR S&P Biotech ETF
$158.251d +2.6%5d +0.9%settled close · 2026-09-17
β 0.9152w $127–170Shares 63.9MNYSE Arca since 2006
The tape, with the calls on it

Who said what, and what XBI did next

Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.

bullish bearish both sides
Who’s talkingIdea Scout · free

Who’s talking about XBI

2 longlatest 2026-06-18
DateVoiceStanceVenueThesis
2026-06-18Joe Terranova (Virtus)Chief market strategist, VirtusBullishCNBC Halftime Final TradesMiddle East conflict resolution is catalyzing a market broadening rotation back into healthcare/biotech, with…
2025-07-18Jc ParetsFounder & Chief Market Strategist, All Star ChartsBullishThe CompoundShort interest in XBI is at multi-year highs, Russell 2000 shorts at record, and historically major market…
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
The options tape

Notable options days

Sessions in the last 120 where XBI’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-15
2026-09-02
2026-08-20
2026-08-19
2026-06-24
2026-06-23
2026-06-22
2026-06-17
2026-06-15
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on XBI is in this morning’s Brief. Get The Brief — $20/mo →